The Pharyngitis Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the pharyngitis treatment market has been showing consistent growth. The market value rose from $2.27 billion in 2024 to $2.37 billion in 2025, marking a compound annual growth rate (CAGR) of 4.5%.
The pharyngitis treatment global market is projected to reach $2.99 billion in 2029, with a compound annual growth rate (CAGR) of 6.0%.
Download Your Free Sample of the 2025 Pharyngitis Treatment Market Report and Uncover Key Trends Now!The key drivers in the pharyngitis treatment market are:
• Adoption of rapid point-of-care tests
• Demand for personalized medicine
• Prevalence of antibiotic resistance
• Rising importance of hand hygiene
The pharyngitis treatment market covered in this report is segmented –
1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes
2) By Source of Infection: Viral, Bacterial
3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery
4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users
The key trends in the pharyngitis treatment market are:
• The adoption of rapid point-of-care tests is driving the market.
• Demand for personalized medicine is becoming a significant trend.
• Rising antibiotic resistance is reshaping the future of pharyngitis treatment.
• The integration of digital health technologies and telehealth is another significant emerging trend.
Major companies in the pharyngitis treatment market are:
• Pfizer Inc.
• GlaxoSmithKline PLC
• Genentech Inc.
• Pliva Hrvatska D.o.o.
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Medtronic PLC
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Fresenius Kabi AG
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Hikma Pharmaceuticals PLC
• Lupin Limited
• LivaNova PLC
North America was the largest region in the pharyngitis treatment market in 2024